Home/Filings/4/0001104659-22-091245
4//SEC Filing

Dahlbeck Scott 4

Accession 0001104659-22-091245

CIK 0001792581other

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 4:31 PM ET

Size

5.0 KB

Accession

0001104659-22-091245

Insider Transaction Report

Form 4
Period: 2022-08-11
Dahlbeck Scott
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-08-11+50,000496,757 total
Footnotes (2)
  • [F1]These shares represent restricted stock units ("RSUs") and will be settled in common stock as soon as practicable within 60 days following vesting. The RSUs vested on August 11, 2022.
  • [F2]Includes (i) 50,000 shares of common stock underlying the RSUs and (ii) 446,757 shares of common stock.

Issuer

Kiromic Biopharma, Inc.

CIK 0001792581

Entity typeother

Related Parties

1
  • filerCIK 0001815317

Filing Metadata

Form type
4
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 4:31 PM ET
Size
5.0 KB